Skip to content

A randomized controlled trial of “structural stress regulation group therapy” in patients with atopic dermatitis

A randomized controlled trial of “structural stress regulation group therapy” in patients with atopic dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061072
Enrollment
Unknown
Registered
2022-06-15
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

2:structural stress regulation group therapy

Sponsors

The Second Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 23 Years

Inclusion criteria

Inclusion criteria: 1. Patients with specific dermatitis diagnosed by dermatologists who meet the "hanifin and Rajka diagnostic criteria"; 2. Students in secondary schools and universities (including junior colleges); 3. Aged 13-23 years.

Exclusion criteria

Exclusion criteria: 1. Currently taking psychiatric drugs; 2. Previous or current stress management or psychotherapy or immunosuppressive therapy; 3. Patients who are seriously ill and have to receive treatment other than topical hormone drugs and emollients; 4. According to the opinion of the researcher, there are any clinically significant abnormal laboratory data, vital signs and physical examination results that will interfere with the safety evaluation at the time of screening or baseline; 5. Patients with serious unstable physical diseases, diagnosed diabetes, thyroid disease, hypertension, heart disease, etc.; 6. Poor command of Mandarin.

Design outcomes

Primary

MeasureTime frame
Eczema area and severity index, EASI;Scoring Atopic Dermatitis Index;Depression-Anxiety-Stress Scale;Dermatology Life Quality Index, DLQI;Perceived Stress Scale;state-trait anxiety inventory, STAI;Adolescent life event questionnaire;Generalized Anxiety Disorder, GAD-7;Patient Health Questionnaire-9, PHQ-9;

Countries

China

Contacts

Public ContactQing Qi

The Second Affiliated Hospital of Guangzhou Medical University

soloqi@hotmail.com+86 13711301232

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026